Adamax Peptide · Research brief

Adamax vs Semax: What the Structure Change Means

Real Peptides Research TeamEditorial

Updated September 29, 20269 min read

52 WORDS

Short answer

Adamax and Semax are built from the exact same seven amino acids in the exact same order. The entire difference in adamax vs semax is two chemical caps, one attached to each end of the chain, and those caps exist for a single purpose: to stop enzymes from cleaving the peptide apart.

Key takeaways

Adamax is N-Acetyl Semax Amidate, the Semax heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro with an acetyl cap on the N-terminus and a carboxamide replacing the C-terminal carboxyl.
The adamax vs semax difference is pharmacokinetic rather than pharmacological: capping the termini blocks exopeptidase cleavage without changing the sequence or its targets.
Semax carries an average molecular weight near 813.9 g/mol and Adamax near 855 g/mol, a gap of roughly 41 Da that mass spectrometry resolves instantly.
NA-Semax is acetylated only, Semax Amidate is amidated only, and Adamax carries both modifications, so all three are chemically distinct compounds.
Terminal capping protects against enzymes, not against oxidation, heat or light, and the N-terminal methionine in both molecules remains oxidation-prone.
Semax has a deep published literature and Russian pharmaceutical registration; Adamax does not, which makes literature comparability the real trade-off.
Neither compound is FDA-approved, and both are supplied for laboratory research only.

Our team fields this question from research buyers almost weekly, and it nearly always arrives phrased as a potency comparison. It isn't one. It's a stability question wearing a potency costume, and the answer lives in the chemistry rather than in vendor copy.

What is the difference between Adamax and Semax?

Adamax is N-Acetyl Semax Amidate: the Semax heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) carrying an acetyl group on its N-terminus and a carboxamide in place of its C-terminal carboxyl group. Semax is the unmodified parent peptide. Both edits block exopeptidase cleavage, so Adamax resists enzymatic breakdown longer under laboratory conditions.

The over-simplification worth killing early is the idea that adamax vs semax is a strength comparison, with Adamax as a concentrated version of the same thing. Terminal modification alters how long a molecule survives intact and how readily it moves across membranes. It does not change which receptors the sequence engages. What follows covers the exact chemistry of acetylation and amidation, how to tell the analog names apart, and what the stability gap does and doesn't mean for a research program.

The two chemical edits that separate the molecules

Semax is a heptapeptide whose first four residues, Met-Glu-His-Phe, correspond to fragment 4 to 7 of adrenocorticotropic hormone (ACTH), the pituitary hormone that normally drives cortisol release. Chemists at the Institute of Molecular Genetics of the Russian Academy of Sciences appended a C-terminal Pro-Gly-Pro tripeptide because the bare ACTH fragment was degraded almost immediately by plasma peptidases. The literature describes the resulting molecule as retaining neurotropic activity while being devoid of the parent hormone's corticotropic effect.

So Semax was already a stability-engineered peptide long before Adamax existed. Adamax applies two further edits to that same backbone:

N-terminal acetylation. An acetyl group of roughly 42 Da replaces a hydrogen on the free alpha-amino group. Aminopeptidases need that free amine to dock and cut. Cap it, and they can't start.
C-terminal amidation. The terminal carboxyl group becomes a carboxamide, a change of about minus 1 Da. Carboxypeptidases need that free carboxyl for the same reason.

Semax carries an average molecular weight near 813.9 g/mol. Capping both ends puts Adamax near 855 g/mol. Each edit also neutralizes one charged terminus, which shifts the molecule toward slightly greater lipophilicity, the property that governs passive diffusion across membranes. In any adamax vs semax comparison, that mass gap of roughly 41 Da is the single most useful identity check a receiving lab has, and it takes one glance at a mass spectrometry trace to confirm.

Sorting out the analog names: NA-Semax, Semax Amidate and Adamax

Four names circulate for three distinct molecules, and buyers conflate them constantly. Adamax is a trade name for N-Acetyl Semax Amidate, sometimes abbreviated NASA, and it carries both terminal modifications. N-Acetyl Semax, usually written NA-Semax, is acetylated only. Semax Amidate is amidated only. Standard Semax has neither.

That resolves the three questions researchers ask most. Adamax vs NA-Semax is a difference of one modification, the C-terminal amide. Semax Amidate compared with plain Semax is also a difference of one modification, in the other direction. Adamax vs semax is a difference of two.

Here's the part most comparisons skip entirely. None of these trade names carries a regulatory definition. No authority certifies what a vial labeled Adamax contains. Semax itself has a registered CAS number, 80714-61-0, while the capped analogs are frequently listed without one, so identity rests entirely on sequence and measured mass. A product page naming an analog while publishing a mass consistent with unmodified Semax is either mislabeled or misanalyzed, and no amount of brand language settles it.

Our team has reviewed enough third-party paperwork to say this plainly: the label is the weakest piece of evidence in the box. Every compound we synthesize in small batches ships with a publicly viewable certificate of analysis carrying purity and mass data precisely so the buyer never has to take a name on faith.

What extra stability does and doesn't buy a research program

Greater enzymatic resistance changes a peptide's pharmacokinetics, not its pharmacology. The published Semax literature reports upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) along with their tyrosine kinase receptors, modulation of dopaminergic and serotonergic signaling, and inhibition of enkephalin-degrading enzymes. Capping the termini of that same sequence doesn't hand it a new target. Studies suggest it buys the intact molecule more time before peptidases reach it.

Two caveats matter more than the stability gain itself.

First, acetylation and amidation defend against enzymatic cleavage, not chemical degradation. Semax opens with methionine, a residue prone to oxidation into methionine sulfoxide, and a terminal cap does nothing to shield that side chain from oxygen, heat or light. Lyophilized powder held at minus 20 degrees Celsius and protected from light remains the standard for both compounds, and peptides sitting in aqueous solution degrade considerably faster than in the dry state.

Second, the evidence base behind adamax vs semax is lopsided. Semax has decades of Russian preclinical and clinical publication behind it and is registered as a pharmaceutical product in Russia. Adamax has a far thinner peer-reviewed record, and much of what circulates about it is structural inference rather than reported data. Neither compound is FDA-approved, and both are supplied strictly for laboratory research. This article is educational: Real Peptides does not provide dosing, preparation or administration guidance for any compound, because these are research-use-only materials.

Adamax vs Semax: structure, stability and evidence compared

The table maps the differences a lab actually acts on when specifying a compound. Every row reflects structural fact or published record rather than vendor positioning.

Attribute	Semax (unmodified)	N-Acetyl Semax Amidate (Adamax)	Bottom Line for Researchers
Terminal chemistry	Free N-terminal amine and free C-terminal carboxyl, both exposed to exopeptidase attack	Acetylated N-terminus and amidated C-terminus, both cleavage docking sites blocked	The distinction is a real, measurable structural change, not a branding exercise
Approximate molecular weight	Near 813.9 g/mol for the seven-residue chain	Near 855 g/mol after adding an acetyl group and converting the carboxyl to carboxamide	A mass roughly 41 Da apart is the fastest confirmation of which molecule arrived
Enzymatic stability	Already extended beyond the bare ACTH fragment by the C-terminal Pro-Gly-Pro tail	Further resistant to aminopeptidase and carboxypeptidase cleavage at both ends	Select on whether the study question concerns the parent compound or degradation kinetics
Published research base	Decades of Russian preclinical and clinical literature; registered as a pharmaceutical in Russia	Sparse peer-reviewed record; much available information is structural rather than experimental	Semax is the defensible choice when results must be compared against prior literature
Oxidation vulnerability	N-terminal methionine oxidizes readily to methionine sulfoxide	Identical N-terminal methionine; acetylation does not protect that side chain	Cold, dark, dry storage matters equally for both compounds
Regulatory status	Not FDA-approved; supplied for laboratory research only	Not FDA-approved; supplied for laboratory research only	Neither may be described, sold or used as a human therapeutic

What If: Analog Selection and Verification Scenarios

What if the certificate of analysis lists a mass that doesn't match the label?

Treat the reported mass as the authoritative identity and the label as unverified until the supplier reconciles the discrepancy. A vial labeled as an amidated or acetylated analog should report a mass consistent with those additions, roughly 41 Da above unmodified Semax when both caps are present. A trade name is not a specification, so a mismatch means either the wrong material shipped or the analysis belongs to a different batch.

What if a protocol specifies Semax but only an analog is in stock?

Substitution changes the compound under study and should be documented as a protocol deviation rather than a like-for-like swap. Comparability with existing Semax literature depends on using the same molecule, since degradation kinetics differ between the capped and uncapped forms. A study designed to extend prior Semax findings loses that anchor the moment an analog is substituted silently.

What if lyophilized powder arrives at ambient temperature?

Record the excursion, inspect the vial, and contact the supplier before the material enters any experiment. Lyophilized peptides tolerate short ambient transit far better than material in solution, which is exactly why they ship dry, but tolerance isn't a guarantee of integrity. Visual inspection cannot detect oxidation of the N-terminal methionine, so documentation and supplier communication carry more weight here than appearance.

What if the published record on Adamax seems thinner than expected?

It is thinner, and that is the accurate picture rather than a gap in your search. Most structural analogs enter the research supply chain well ahead of independent publication, so the available information is predominantly chemical rather than experimental. Researchers building on established findings generally work from the parent compound and treat the analog as a separate line of inquiry.

The straight answer on which analog is better

Here's the honest answer: nobody can tell you that Adamax outperforms Semax, because the head-to-head comparative literature simply doesn't exist. What exists is a structural argument. Blocking both termini demonstrably slows exopeptidase cleavage, and that is chemistry, not speculation. What has not been established in published, peer-reviewed work is whether that added stability translates into a meaningfully different research outcome. Anyone framing adamax vs semax as a settled question of superiority is extrapolating from structure to effect, and that extrapolation is exactly where peptide marketing tends to outrun peptide science.

Researchers working through these distinctions can review the Semax research collection, compare listings for Adamax Peptide and Semax Amidate, examine the closely related Selank Amidate, and check identity data against our published certificates of analysis or browse the full research catalog. All compounds are supplied for laboratory research only.

The adamax vs semax decision rarely turns on which molecule is stronger, because that framing was never the right one. It turns on whether a study needs comparability with an existing body of literature or wants to probe what happens when degradation is slowed at both ends of a well-characterized sequence. Those are different questions with different correct answers, and the peptide itself is indifferent to which one you're asking. Verify the mass, read the certificate, and let the structure tell you what you actually received.

References

Peer-reviewed sources on Semax indexed in PubMed, listed for research context. Real Peptides supplies Semax for laboratory research use only.

The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease. Acta naturae, 2025. PMID 41479572. doi:10.32607/actanaturae.27808
Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing. Bioinorganic chemistry and applications, 2025. PMID 40496623. doi:10.1155/bca/4226220
Functional Connectomic Approach to Studying Selank and Semax Effects. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2020. PMID 32342318. doi:10.1134/S001249662001007X
Novel Insights into the Protective Properties of ACTH((4-7))PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats. Genes, 2020. PMID 32580520. doi:10.3390/genes11060681
Influence of ACTG(4-7)-PGP (Semax) on Morphofunctional State of Hepatocytes in Chronic Emotional and Painful Stress. Bulletin of experimental biology and medicine, 2017. PMID 28577097. doi:10.1007/s10517-017-3748-4
Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2017. PMID 28702721. doi:10.1134/S0012496617030048
Semax prevents learning and memory inhibition by heavy metals. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2016. PMID 27411820. doi:10.1134/S0012496616030066
The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study. Journal of molecular neuroscience : MN, 2011. PMID 20617398. doi:10.1007/s12031-010-9421-2

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

No. Adamax is N-Acetyl Semax Amidate, which is the Semax heptapeptide sequence Met-Glu-His-Phe-Pro-Gly-Pro with an acetyl group added to the N-terminus and the C-terminal carboxyl converted to a carboxamide. The amino acid sequence is identical, but the two terminal modifications make it a chemically distinct molecule with a molecular weight roughly 41 Da higher.

Adamax is the more enzymatically stable of the two because both of its termini are capped. Aminopeptidases require a free N-terminal amine and carboxypeptidases require a free C-terminal carboxyl, and acetylation and amidation remove those recognition points respectively. That stability advantage applies to enzymatic cleavage only, not to oxidation, heat or light exposure.

The name describes two specific chemical modifications applied to the Semax sequence. N-Acetyl means an acetyl group, roughly 42 Da, has replaced a hydrogen on the free alpha-amino group at the start of the chain. Amidate means the terminal carboxyl group at the other end has been converted into a carboxamide, a change of about minus 1 Da.

NA-Semax, or N-Acetyl Semax, carries the N-terminal acetyl group only. Adamax carries that same acetyl group plus a C-terminal amide. The practical consequence is that NA-Semax still has an exposed free carboxyl at the C-terminus, which remains a viable cleavage site for carboxypeptidases, while Adamax has both ends blocked.

Semax Amidate carries a single modification, the C-terminal carboxamide, while standard Semax has both termini free. The amidation blocks carboxypeptidase cleavage and removes one negative charge from the molecule. Standard Semax remains the form with the deepest published research record, including Russian preclinical and clinical literature dating back decades.

Neither compound is FDA-approved. Semax is registered as a pharmaceutical product in Russia, where it was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, but that registration carries no standing with United States regulators. Both Semax and Adamax are supplied in the US strictly as research-use-only materials for laboratory work.

These compounds are supplied to researchers, laboratories and institutions conducting in-vitro or preclinical work. They are not sold or supplied for human or veterinary consumption, and they are not therapeutic products. Buyers are responsible for handling the material in accordance with their institution's research protocols and applicable regulations.

No. Real Peptides does not publish dosing, preparation or administration guidance for any compound, because every item in the catalog is a research-use-only material rather than a therapeutic product. What we do publish is identity and purity data on the certificate of analysis, including the stated milligram content of the vial, so a research team can perform its own concentration calculations within its own protocol.

Lyophilized peptide powder is generally held at minus 20 degrees Celsius, protected from light and moisture. Peptides in aqueous solution degrade considerably faster than material kept in the dry lyophilized state. Terminal acetylation and amidation improve resistance to enzymatic cleavage but offer no protection against oxidation, so the N-terminal methionine in both compounds remains vulnerable to oxygen, heat and light.

Acetylation changes how long the molecule survives intact, not which receptors the sequence engages. Potency and stability are separate properties, and no published head-to-head study establishes that the capped analog produces a different research outcome than the parent peptide. Any claim of superior potency is an extrapolation from structure rather than a reported experimental finding.

Compare the measured mass on the certificate of analysis against the expected value. Unmodified Semax has an average molecular weight near 813.9 g/mol, while the doubly capped Adamax sits near 855 g/mol, a difference of roughly 41 Da that mass spectrometry resolves clearly. Semax also has a registered CAS number, 80714-61-0, whereas the capped analogs are often sold without one, which makes sequence and mass data the primary identity evidence.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA